Hemolytic disease of the newborn, also called hemolytic disease of the fetus and newborn or erythroblastosis fetalis, is an alloimmune condition that develops in a fetus at or around birth, when IgG antibodies produced by the mother pass through the placenta and attack antigens on the red blood cells in the fetal circulation, breaking down and destroying the cells. The fetus can develop reticulocytosis and anemia, and the intensity of the disease ranges from mild to very severe, with fetal death from heart failure possible in severe cases. When the disease is moderate or severe, many erythroblasts appear in the fetal blood, which is why the more severe forms are called erythroblastosis fetalis.
Facts
Classification
ICD-10 ChapterXVI: Certain Conditions Originating in the Perinatal Period 2 Communicable or Non-communicable Connections
Associated With
Discovery of the Rh blood group factor directly explained the maternal-fetal blood incompatibility that causes hemolytic disease of the newborn.
Treated By
Blood (exchange) transfusion is standard treatment for severe hemolytic disease of the newborn.
Sources
1. Wikipedia: Hemolytic disease of the newborn
WikipediaLead section, body-system statement
Hemolytic disease of the newborn (HDN), hemolytic disease of the fetus and newborn (HDFN) or erythroblastosis fetalis, is an alloimmune condition that develops in a fetus at or around birth, when the IgG molecules (one of the five main types of antibodies) produced by the mother pass through the placenta.
Lead section, body-system statement (cardiovascular)
The intensity of this fetal disease ranges from mild to very severe, and fetal death from heart failure (hydrops fetalis) can occur.
View the Source 2. Wikipedia: ICD-10
WikipediaList of chapters, Chapter XVIQuote, List of chapters, Chapter XVI
Certain conditions originating in the perinatal period
View the Source Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.